Request for International Influenza Molecular Diagnostic Performance Evaluation Panel

Español | Other Languages

CDC’s Influenza Division is offering a CDC Influenza Molecular Diagnostic Performance evaluation Panel to bi-lateral cooperative agreement countries during the Fall of 2014. This panel consists of nine mock human specimens requiring identification of types A and B, and characterization of subtype and/or genotype to evaluate the performance of the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel kits for Influenza A/B typing (RUO-1) Influenza A subtyping (RUO-2), Influenza B Lineage Genotyping (RUO-4), Influenza A/H7 (Eurasian Lineage) subtyping (FluEUA-01) and Influenza A/H5 subtyping (RUO03-3). The purpose of this exercise is to assist CDC and its grantees in understanding the performance of the CDC Flu rRT-PCR Panel reagents internationally, and to identify any PCR testing issues that can be addressed in future trainings and workshops. Although participation in this exercise is encouraged, it is strictly voluntary.

Grantees are encouraged to participate and should submit the enrollment information by August 18, 2014.

For general assistance and questions regarding submitting requests, please contact FluPEP@cdc.gov.

Note: All fields are required unless otherwise indicated.

Laboratory Point of Contact:

Prefix:

Last Name:

First Name:

Phone Number:

Email Address:

Laboratory Name:

Laboratory Address:

Street Address:

City:

Province:

Country:

Postal Code:

Shipping Point of Contact: